Cherry Tree Wealth Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.95K Hold
63
﹤0.01% 500
2025
Q4
$6.01K Hold
63
﹤0.01% 474
2025
Q3
$6.15K Sell
63
-150
-70% -$15.5K ﹤0.01% 456
2025
Q2
$22.9K Sell
213
-41
-16% -$4.15K 0.01% 328
2025
Q1
$25.6K Hold
254
0.01% 315
2024
Q4
$22.7K Sell
254
-118
-32% -$10.4K 0.01% 321
2024
Q3
$31.2K Sell
372
-199
-35% -$15.7K 0.01% 298
2024
Q2
$44K Hold
571
0.01% 257
2024
Q1
$39.1K Hold
571
0.01% 271
2023
Q4
$33K Hold
571
0.01% 269
2023
Q3
$30.1K Buy
571
+63
+12% +$3.3K 0.01% 262
2023
Q2
$27.5K Buy
+508
New +$26.5K 0.01% 268

Other funds holding BSX

Cherry Tree Wealth Management's BSX Position: Q1 2026 in Review

Cherry Tree Wealth Management held its Boston Scientific (BSX) position steady in Q1 2026 at 63 shares worth $3.95K. The position accounts for ﹤0.01% of the portfolio, ranked #500.

Cherry Tree Wealth Management first reported a position in BSX in Q2 2023 and has held it in 12 quarters since. The position peaked at $44K in Q2 2024. 1,676 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Cherry Tree Wealth Management held 63 shares of Boston Scientific worth $3.95K as of Q1 2026.
  • Cherry Tree Wealth Management left its Boston Scientific share count unchanged in Q1 2026.
  • Boston Scientific made up ﹤0.01% of Cherry Tree Wealth Management's portfolio in Q1 2026, its #500 holding.
  • Cherry Tree Wealth Management first reported a position in Boston Scientific in Q2 2023 and has held it in 12 quarters since.
  • Cherry Tree Wealth Management's Boston Scientific position peaked at $44K in Q2 2024.
  • 1,676 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Cherry Tree Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.